Maureen Dubreuil, MD, MSc.

Dr. Dubreuil is a rheumatologist in Boston, specializing in spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. Dr. Dubreuil's research has been funded by numerous competitive grants from funders including the NIH, private foundations and industry. Some highlights of Dr. Dubreuil's work includes:
1. Discovery of two key protective effects of TNF inhibitors against fractures and cardiovascular events in spondyloarthritis
2. Finding that a common nonsteroidal anti-inflammatory drug is associated with 3 times the risk of heart attack among people with spondyloarthritis
3. Development of the first North American guidelines for referral of adults at increased risk of having spondyloarthritis to a rheumatologist

In addition to her research, Dr. Dubreuil is a member of the leading international organizations for spondyloarthritis research. She serves on the Executive Committee of the Board of Directors for the Spondyloarthritis Research and Treatment Network, and on the Medical Advisory Board for the Spondylitis Association of America. She is a site investigator for the international CLASSIC study in spondyloarthritis. Dr. Dubreuil is the Director of Research Training for the Rheumatology Fellowship program at Boston Medical Center.

Dr. Dubreuil cares for people with rheumatic conditions at Boston Medical Center and the VA Boston Healthcare System. Dr. Dubreuil's patients say the following about her:
"Dr. Dubreuil is a very caring and knowledgeable doctor and it's always a pleasure to be seen by her."
"I am very satisfied with the care I have received. My provider and the support staff is very professional, caring and concerned. I would recommend to anyone."
"Dr. Dubreuil is a gem and I feel so lucky to have her!"

Diversity, Equity, Inclusion and Accessibility

Dr. Dubreuil is a participant in the Rheumatology Section monthly journal club focused on Justice, Equity, Diversity and Inclusion (JEDI).
Additionally, as a leader for the weekly Research Accelerator meeting, Dr. Dubreuil addresses topic of research equity, and guides discussion around studies addressing disparities in treatment and outcomes.
Dr. Dubreuil was the invited moderator for the 2023 Unmet Research Needs in Spondyloarthritis session on Health Outcomes, Social Constructs and Disparities.
Additionally Dr. Dubreuil is grateful to be the recipient of grant funding from the Arthritis Foundation to study disparities in time to diagnosis of Axial Spondyloarthritis: https://stage.arthritis.org/news/stories-of-yes/2022-dei-award-maureen-dubreuil

Member
Boston University
Arthritis & Autoimmune Diseases Research Center


VA Boston Healthcare System




Protocol I1F-MC-B019: Psoriatic Arthritis Real-World Study in the US (PARTUS)
10/17/2023 - 10/17/2027 (Subcontract PI)
United BioSource LLC Eli Lilly and Co


Delay in diagnosis of ankylosing spondylitis: Do race, ethnicity or social determinants of health matter?
01/01/2023 - 12/31/2024 (PI)
Arthritis Foundation


SPARTAN Referral Recommendations
07/01/2021 - 12/31/2024 (PI)
SpondyloArthritis Research and Treatment Network


Career Development Bridge Funding Award: R Bridge
11/01/2022 - 10/30/2024 (PI)
Rheumatology Research Foundation


Effects of Janus kinase inhibitors on structural and safety outcomes in spondyloarthritis
06/16/2022 - 10/31/2023 (PI)
Pfizer, Inc.


Risk of fractures, joint replacements and adverse pregnancy outcomes in ankylosing spondylitis
07/01/2020 - 06/30/2023 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5R03AR076495-02

Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC)
12/23/2019 - 12/22/2022 (PI)
SpondyloArthritis Research and Treatment Network


Establishing The Value of Treatment Strategies in Spondyloarthritis
05/01/2016 - 04/30/2022 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5K23AR069127-05

Cardiovascular disease and diabetes in Ankylosing Spondylitis
07/01/2013 - 12/30/2015 (PI)
Arthritis Foundation



Boston University Advanced Fellowship in Psoriatic Arthritis Clinical and Research Excellence
07/01/2020 - 06/30/2025 (PI)
Pfizer, Inc


Title

Boston University Clinical and Translational Science Institute
01/01/2019 - 12/31/2020 (PI)
BU CTSI

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Dubreuil M, Ferucci ED, El-Gabalawy H, Hasni S, Williams EM. Enhancing Equity in Clinical Research: A Multifaceted Proposal for Spondyloarthritis. J Rheumatol. 2024 Oct 24. PMID: 39448246
     
  2. Colbert RA, Carroll E, Dubreuil M, Gensler LS, Haroon N, Howard R, Ogdie AR, Shafer C, Weiss PF, Kuhn KA. Prologue: Spondyloarthritis Unmet Research Needs Conference IV. J Rheumatol. 2024 Oct 24. PMID: 39448249
     
  3. Navarro-Compán V, Rudwaleit M, Dubreuil M, Magrey M, Marzo-Ortega H, Mease PJ, Walsh JA, Dougados M, de la Loge C, Fleurinck C, Massow U, Vaux T, Taieb V, Deodhar A. Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies. J Rheumatol. 2024 Oct 15. PMID: 39406403
     
  4. Dubreuil M, Navarro-Compán V, Boonen A, Gaffney K, Gensler LS, de la Loge C, Vaux T, Fleurinck C, Massow U, Taieb V, Mørup MF, Deodhar A, Rudwaleit M. Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies. RMD Open. 2024 Jun 04; 10(2). PMID: 38834351; PMCID: PMC11163688; DOI: 10.1136/rmdopen-2024-004202;
     
  5. Liew JW, Treu T, Park Y, Ferguson JM, Rosser MA, Ho YL, Gagnon DR, Stovall R, Monach P, Heckbert SR, Gensler LS, Liao KP, Dubreuil M. The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2024 Oct; 68:152482.View Related Profiles. PMID: 38865875; PMCID: PMC11381167; DOI: 10.1016/j.semarthrit.2024.152482;
     
  6. Dubreuil M. Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings. Curr Rheumatol Rep. 2024 May; 26(5):164-169. PMID: 38340269
     
  7. Jinno S, Onishi A, Hattori S, Dubreuil M, Ueda Y, Nishimura K, Okano T, Yamada H, Yamamoto W, Murata K, Onizawa H, Ebina K, Maeda Y, Son Y, Amuro H, Hara R, Hata K, Shiba H, Katayama M, Watanabe R, Hashimoto M, Saegusa J. Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study. Rheumatology (Oxford). 2024 Feb 06. PMID: 38317442
     
  8. Bittar M, Nouer SS, Tolley EA, Dubreuil M, Magrey M. Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors. Clin Rheumatol. 2024 Jan; 43(1):227-232. PMID: 37733078
     
  9. George N, Liew JW, Dubreuil M. The role of upadacitinib for the treatment of axial spondyloarthritis. Immunotherapy. 2023 Oct; 15(15):1227-1237.View Related Profiles. PMID: 37675498
     
  10. Merjanah S, Liew JW, Bihn J, Fillmore NR, Brophy MT, Do NV, Dubreuil M. Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2023 Dec; 75(12):2481-2488.View Related Profiles. PMID: 37308459; PMCID: PMC10704387; DOI: 10.1002/acr.25166;
     
Showing 10 of 67 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 67 publications over 16 distinct years, with a maximum of 13 publications in 2021

YearPublications
20001
20091
20101
20121
20134
20141
20152
20165
20175
20187
20194
20207
202113
20221
20237
20247

2024-2025 Boston Medical Center/Boston University Department of Medicine: R Bridge Award
2023-2024 Boston University Chobanian & Avedisian School of Medicine, Department of Medicine: R Bridge Award
2022-2023 Doris Duke Charitable Foundation: Scientist Retention Award
2022-2024 Rheumatology Research Foundation: R Bridge Award
2022-2024 Boston University Clinical and Translational Science Institute: Informatics Award (UL1 TR 001430)
2022-2023 Arthritis Foundation: Research Grant: "Delay in diagnosis of ankylosing spondylitis"
2022-2024 Pfizer: Investigator-Initiated Research Grant: "Effects of Janus kinase inhibitors in spondyloarthritis"
2022-2024 Spondyloarthritis Research and Treatment Network: Project Award: "Development of Referral Recommendations in Spondyloarthritis"
2020-2022 NIH/NIAMS: R03: "Risk of Fractures & Joint Replacement Surgeries w/TNF-inhibitors in Ankylosing Spondylitis"
2019-2020 Boston University Clinical and Translational Science Institute: Pilot Grant: “Risk of joint replacement surgery in ankylosing spondylitis”
2018 Spondylitis Association of America:: Early Career Investigator Award
2018 Spondyloarthritis Research and Treatment Network : Seed Grant
2017 Boston University Department of Medicine: Evans Junior Merit Award
2016-2021 NIH/NIAMS: K23 Career Dev. Grant: "Establishing the Value of Treatment Strategies in Ankylosing Spondylitis"
2016-2020 Boston University School of Public Health and Optum Labs Visiting Scholar
2016-2017 Boston University Clinical and Translational Science Institute: Pilot Grant: “Identifying incident cases of knee osteoarthritis in THIN, a large database”
2015-2020 Boston University Department of Medicine: Career Investment Award
2013-2015 Arthritis Foundation: Research Scientist Development Award
2011-2013 NIH/NIAMS: T32 Training Grant
2009 Gold Humanism in Medicine Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Spondyloarthritis, Ankylosing
Psoriatic Arthritis
Epidemiology
Pharmacoepidemiology
NSAIDs
Spondyloarthropathies
Spondyloarthritides, Ankylosing

I have mentored Master-level SPH students and fellows in projects related to epidemiology of rheumatologic diseases and pharmacoepidemiology. These projects have culminated in publications, a Master degree thesis, as well as poster and oral presentations at national meetings. I hope to continue mentoring trainees who have interests in epidemiology related to specific research projects, development of research themes, or development of grant applications.

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
Dubreuil's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department